Cytosorbents Corporation
CTSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,719 | -$28,507 | -$32,813 | -$24,559 |
| Dep. & Amort. | $1,750 | $2,027 | $1,132 | $1,130 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,760 | $3,701 | $3,800 | $6,204 |
| Change in WC | -$4,378 | $2,361 | -$3,562 | $642 |
| Other Non-Cash | $5,159 | -$1,236 | $3,208 | $2,577 |
| Operating Cash Flow | -$14,428 | -$21,655 | -$28,234 | -$14,006 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$669 | -$936 | -$6,456 | -$4,281 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$669 | -$936 | -$6,456 | -$4,281 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,000 | $0 | $5,000 | $0 |
| Stock Issued | $179 | $14,256 | -$40 | $715 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$848 | $218 | $0 | $0 |
| Financing Cash Flow | $9,331 | $14,474 | $4,960 | $715 |
| Forex Effect | -$85 | -$100 | -$263 | -$25 |
| Net Chg. in Cash | -$5,851 | -$8,217 | -$29,993 | -$17,596 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,615 | $23,832 | $53,825 | $71,422 |
| End Cash | $9,764 | $15,615 | $23,832 | $53,825 |
| Free Cash Flow | -$14,712 | -$22,591 | -$34,690 | -$18,287 |